Preferred Reporting Items for Systematic Reviews and Meta-Analyses – Artificial Intelligence Extension
Condition(s):Consensus DevelopmentLast Updated:May 19, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Consensus DevelopmentLast Updated:May 19, 2022Enrolling by invitation
Condition(s):Cardiovascular Diseases; Coronary Heart Disease; Stroke; Diabetes Mellitus, Type 2; Hypertension; ObesityLast Updated:June 13, 2018Unknown status
Condition(s):Venous ThromboembolismLast Updated:April 19, 2012Withdrawn
Condition(s):Metabolic Syndrome; Overweight; Obesity; Chronic Inflammation; Cardiovascular DiseasesLast Updated:August 18, 2022Completed
Condition(s):Peripheral Arterial Disease; Intermittent ClaudicationLast Updated:March 10, 2020Completed
Condition(s):Sepsis; Septic; SepticemiaLast Updated:February 21, 2014Unknown status
Condition(s):Hypercholesterolemia; Cardiovascular Risk FactorLast Updated:November 17, 2017Unknown status
Condition(s):Chronic Kidney DiseaseLast Updated:November 21, 2014Completed
Condition(s):DiabetesLast Updated:November 9, 2015Unknown status
Condition(s):Diabetes; Prediabetes; Metabolic Syndrome; Dysglycemia; Overweight; Obesity; Dyslipidemia; Hypertension; Gout; Non-alcoholic Fatty Liver Disease (NAFLD); Kidney Disease; Kidney Injury; Cardiovascular DiseaseLast Updated:May 27, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.